StonvexLoading…
StonvexStonvexStonvexCore line items from ULBI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $47.45M | $191.16M | $142.68M | $99.31M |
Operating Income | $-215.00K | $-5.90M | $4.70M | $5.66M |
Net Income | $-451.00K | $-5.90M | $1.52M | $2.74M |
EPS (Diluted) | $-3.00 | $-35.00 | $0.09 | $0.17 |
Total Assets | $220.63M | $216.91M | $222.25M | $220.96M |
Total Liabilities | $90.89M | $86.78M | $84.81M | $82.32M |
Cash & Equivalents | $8.89M | $9.35M | $9.26M | $10.94M |
Free Cash Flow OCF − CapEx | $1.49M | $7.12M | $6.51M | $7.31M |
Shares Outstanding | 16.66M | 16.66M | 16.65M | 16.64M |